If you lock down before the horse has left the barn, you get a good outcome/Seattle Times

This HHS chart indicates that vaccine will be distributed in early November, after which “monitoring effectiveness and safety” begins. Here is an excellent H1N1 swine flu links page from the National Library of Medicine. This DHHS/DHS document explains the plan for priority targeting of (pandemic) influenza vaccinations. According to FDA: Through an Emergency Use Authorization…

Sotrovimab, a treatment from Vir Biotechnology and GlaxoSmithKline, is expected to remain effective against omicron. https://www.washingtonpost.com/health/2021/12/16/monoclonal-antibody-sotrovimab/ With the omicron variant of the coronavirus poised to thwart most covid-19 treatments, U.S. public health officials are stockpiling the one monoclonal antibody that remains effective so that it can be deployed when the variant becomes more prevalent. The decision to…

Only companies and individuals dealing with “Covered Countermeasures” have their liability waived.  Below is the definition of a covered countermeasure. For a drug or vaccine to be a covered countermeasure, it has to be designated as an Emergency Use Authorized product.  Licensed products, being used for their licensed indication, are not permitted to be authorized…

The 1978 National Academy of Sciences (NAS) report on the 1976 Swine Flu Vaccination Program points out that a large number of assumptions going into the program were never acknowledged or critically examined. For example, the report lists the following assumptions that were made when the program was conceived: high-yield eggs, one dose per person,…

 https://www.bitchute.com/video/D9lkXR9qXkiv/

1.  How widely was Pandemrix vaccine used? Virtually all the narcolepsy data comes from Europe, where the GlaxoSmithKline Pandemrix swine flu vaccine was given to about 31 million Europeans and was used in 47 countries.  It was used in Canada (12 million doses) and a number of developing countries, but little is known about increased cases…